Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Is Intuitive Surgical Stock Outperforming the Dow?
Morgan Stanley Upgrades Intuitive Surgical to Overweight
Morgan Stanley Initiates Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $650
Intuitive Surgical (ISRG) Gets a Buy From Leerink Partners
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
Unpacking the Latest Options Trading Trends in Intuitive Surgical
Are Wall Street Analysts Predicting Intuitive Surgical Stock Will Climb or Sink?
Intuitive Surgical, Inc. (NASDAQ:ISRG) Is Largely Controlled by Institutional Shareholders Who Own 87% of the Company
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $561
BTIG Adjusts Price Target on Intuitive Surgical to $561 From $535, Maintains Buy Rating
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Express News | Intuitive Surgical Inc : Leerink Partners Raises Target Price to $590 From $548
Intuitive Surgical Stock Hits 52-week High at $552
Citi Research's U.S. Equity Strategy Large-Cap Recommendation List
5 Non-Tech Nasdaq Composite High Flyers to Buy for More Gains Ahead
Intuitive Surgical Analyst Ratings
JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Erste Group Initiates Intuitive Surgical(ISRG.US) With Buy Rating